Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 133rd ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PEPG	PEPGEN INC	$152.85M	-92.50%	-70.40%	-113.57%	-103.30%	0.44	4.74	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$381.55M	-27.10%	-26.10%	-29.65%	-29.50%	0.05	25.13	N/A	N/A	N/A
BCDA	BIOCARDIA INC	$8.12M	-19,117.40%	-246.90%	566.26%	1,025.50%	-2.11	0.33	N/A	N/A	N/A
CELC	CELCUITY INC	$3.27B	-150.10%	-64.70%	-94.47%	-50.10%	3.14	4.58	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$1.32B	-59.20%	-50.60%	-73.70%	-252.80%	0.22	5.23	100.00%	-1,180.00%	-1,178.41%
KOD	KODIAK SCIENCES INC	$957.39M	-155.30%	-63.30%	-88.53%	-66.90%	2.65	3.48	N/A	N/A	N/A
ACXP	ACURX PHARMACEUTICALS INC	$7.96M	-436.80%	-192.20%	-280.37%	362.90%	0.73	2.38	N/A	N/A	N/A
DRTS	ALPHA TAU MEDICAL LTD	$354.20M	-51.20%	-38.20%	-31.98%	-37.50%	0.28	10.52	N/A	N/A	N/A
VIR	VIR BIOTECHNOLOGY INC	$827.94M	-50.20%	-40.80%	-50.57%	-55.80%	0.26	7.01	96.10%	-2,895.90%	-2,894.48%
INMB	INMUNE BIO INC	$48.65M	-172.00%	-134.50%	-191.87%	1,346.60%	0.31	4.17	100.00%	-99,774.00%	-99,774.00%
NMRA	NEUMORA THERAPEUTICS INC	$489.08M	-99.00%	-87.70%	-124.29%	-257.40%	0.22	10.54	N/A	N/A	N/A
ACLX	ARCELLX INC	$4.97B	-35.30%	-22.70%	-36.07%	-35.20%	0.56	4.93	100.00%	-211.50%	-251.56%
ELVN	ENLIVEN THERAPEUTICS INC	$1.39B	-29.20%	-27.90%	-20.51%	-43.10%	0.03	32.58	N/A	N/A	N/A
IMMX	IMMIX BIOPHARMA INC	$105.93M	-130.00%	-86.30%	-197.03%	1,814.20%	1.07	1.80	N/A	N/A	N/A
JBIO	JADE BIOSCIENCES INC	$319.74M	-52.00%	-47.60%	-27.81%	-211.00%	0.11	10.31	N/A	N/A	N/A
IMMP	IMMUTEP LTD	$276.01M	-36.90%	-34.30%	-42.57%	-130.80%	0.09	11.69	100.00%	-594.60%	-594.28%
JANX	JANUX THERAPEUTICS INC	$1.70B	-9.30%	-8.90%	-7.52%	-10.40%	0.04	58.47	100.00%	-832.70%	-832.71%
CLNN	CLENE INC	$124.88M	N/A	-111.70%	-184.73%	-112.90%	-3.59	1.58	80.40%	-10,386.40%	-9,398.60%
SAVA	CASSAVA SCIENCES INC	$157.48M	-93.30%	-74.90%	-139.88%	2,577.00%	0.54	2.43	N/A	N/A	N/A
OABI	OMNIAB INC	$190.19M	-22.80%	-20.20%	-24.15%	-83.90%	0.13	3.77	98.90%	-275.80%	-296.89%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$270.73M	-24.90%	-17.80%	-28.76%	-206.10%	0.34	5.90	100.00%	-49.30%	-61.89%
PDSB	PDS BIOTECHNOLOGY CORP	$43.60M	-184.60%	-79.00%	-118.39%	-336.00%	1.54	2.92	N/A	N/A	N/A
ACOG	ALPHA COGNITION INC	$100.04M	-72.00%	-53.60%	-47.34%	-5,948.70%	0.42	14.69	70.10%	-436.40%	-434.42%
INO	INOVIO PHARMACEUTICALS INC	$124.89M	-158.30%	-93.40%	-240.23%	-230.40%	1.39	1.66	100.00%	-48,131.40%	-48,131.35%
MRSN	MERSANA THERAPEUTICS INC	$47.81M	N/A	-57.90%	-278.51%	-11,474.40%	-2.59	1.35	100.00%	-212.90%	-202.14%
TARA	PROTARA THERAPEUTICS INC	$199.85M	-36.90%	-33.80%	-34.56%	-83.20%	0.09	12.82	N/A	N/A	N/A
SPRC	SCISPARC LTD	$1.68M	79.70%	58.40%	74.02%	127.40%	0.17	5.36	38.70%	481.20%	507.12%
QCLS	Q/C TECHNOLOGIES INC	$6.98M	-103.90%	-51.70%	-59.60%	-203.20%	1.05	0.93	N/A	N/A	N/A
CCCC	C4 THERAPEUTICS INC	$185.76M	-53.90%	-33.30%	-44.21%	-38.10%	0.70	5.06	100.00%	-325.90%	-325.50%
XENE	XENON PHARMACEUTICALS INC	$3.23B	-38.50%	-36.50%	-44.07%	-45.70%	0.06	15.14	100.00%	-3,709.70%	-3,767.93%
COGT	COGENT BIOSCIENCES INC	$2.28B	-120.20%	-89.40%	-131.13%	-158.00%	0.77	4.19	N/A	N/A	N/A
ANRO	ALTO NEUROSCIENCE INC	$384.22M	-44.80%	-37.10%	-42.03%	-302.20%	0.28	18.43	N/A	N/A	N/A
QLGN	QUALIGEN THERAPEUTICS INC	$4.83M	N/A	-203.10%	380.76%	-871.00%	-3.40	0.71	N/A	N/A	N/A
HCWB	HCW BIOLOGICS INC	$8.33M	N/A	-77.00%	-506.13%	-115.00%	-557.25	0.11	100.00%	-12,940.00%	-6,270.17%
ENLV	ENLIVEX THERAPEUTICS LTD	$25.05M	-58.30%	-50.30%	-79.72%	-2,051.00%	0.19	6.41	N/A	N/A	N/A
BCAB	BIOATLA INC	$33.96M	-357.90%	-111.70%	-277.67%	601.20%	69.00	2.35	100.00%	-562.50%	-562.51%
AGIO	AGIOS PHARMACEUTICALS INC	$2.52B	-28.40%	-26.40%	-31.29%	-28.90%	0.08	13.82	87.20%	-895.90%	-915.68%
ARTV	ARTIVA BIOTHERAPEUTICS INC	$101.86M	-42.60%	-37.80%	-47.37%	-46.40%	0.14	13.84	N/A	N/A	N/A
CRNX	CRINETICS PHARMACEUTICALS INC	$4.08B	-30.90%	-28.10%	-25.17%	-35.80%	0.09	22.53	100.00%	-43,191.10%	-43,191.05%
TVGN	TEVOGEN BIO HOLDINGS INC	$123.53M	N/A	-782.00%	822.83%	1,528.10%	-1.45	0.26	N/A	N/A	N/A
VERU	VERU INC	$43.22M	-137.20%	-81.60%	-155.40%	-430.50%	0.78	2.42	40.40%	-491.40%	-482.04%
SABS	SAB BIOTHERAPEUTICS INC	$30.20M	-105.10%	-69.20%	-119.31%	-94.10%	0.78	1.69	100.00%	-9,071.80%	-8,989.31%
OCS	OCULIS HOLDING AG	$1.08B	-90.60%	-68.00%	-73.57%	-171.60%	0.27	4.55	100.00%	-21,316.10%	-21,176.59%
CLRB	CELLECTAR BIOSCIENCES INC	$10.82M	-265.50%	-125.70%	-370.52%	391.30%	1.02	2.15	N/A	N/A	N/A
CHRS	COHERUS ONCOLOGY INC	$194.77M	N/A	-26.20%	-97.17%	-41.20%	-3.02	1.22	56.60%	-66.30%	-57.09%
OLMA	OLEMA PHARMACEUTICALS INC	$615.65M	-42.60%	-38.60%	-40.79%	-53.10%	0.11	11.09	N/A	N/A	N/A
ATON	ALPHATON CAPITAL CORP	$8.50M	-347.70%	-135.50%	-602.49%	2,165.50%	-24.81	2.02	N/A	N/A	N/A
QNCX	QUINCE THERAPEUTICS INC	$88.63M	-186.10%	-42.10%	-44.55%	-92.30%	8.99	5.00	N/A	N/A	N/A
GLTO	GALECTO INC	$9.70M	-108.10%	-95.40%	-149.96%	-1,120.10%	0.25	4.96	N/A	N/A	N/A
HYPD	HYPERION DEFI INC	$36.90M	-878.40%	-182.10%	-83.30%	-315.90%	0.49	0.91	-7,177.30%	-90,270.20%	-85,006.99%
NUVL	NUVALENT INC	$7.22B	-39.50%	-35.70%	-42.75%	-44.00%	0.16	10.73	N/A	N/A	N/A
KRRO	KORRO BIO INC	$384.18M	-61.50%	-42.90%	-55.90%	-48.60%	0.57	5.98	100.00%	-1,454.50%	-1,452.95%
SVRA	SAVARA INC	$717.27M	-69.10%	-54.80%	-73.49%	-55.80%	0.36	11.08	N/A	N/A	N/A
RCUS	ARCUS BIOSCIENCES INC	$2.13B	-68.20%	-31.30%	-44.93%	-44.90%	1.23	3.65	100.00%	-142.10%	-138.33%
LXEO	LEXEO THERAPEUTICS INC	$540.55M	-94.70%	-73.40%	-78.94%	-163.10%	0.27	4.43	N/A	N/A	N/A
GRI	GRI BIO INC	$4.28M	-390.20%	-228.00%	-297.74%	764.00%	0.71	2.42	N/A	N/A	N/A
OKUR	ONKURE THERAPEUTICS INC	$45.87M	-81.00%	-74.20%	-89.08%	-72,249.10%	0.10	11.13	N/A	N/A	N/A
AURA	AURA BIOSCIENCES INC	$380.79M	-64.40%	-54.20%	-53.41%	-72.20%	0.17	12.39	N/A	N/A	N/A
ALLO	ALLOGENE THERAPEUTICS INC	$275.13M	-58.60%	-44.80%	-53.74%	-52.10%	0.37	8.92	N/A	N/A	N/A
ACHV	ACHIEVE LIFE SCIENCES INC	$177.59M	-176.10%	-103.30%	-220.53%	-133.50%	1.66	3.51	N/A	N/A	N/A
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$148.90M	-43.70%	-39.60%	-51.52%	-48.90%	0.13	9.21	N/A	N/A	N/A
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$40.80M	N/A	-259.20%	6,117.56%	227.00%	-26.34	0.90	N/A	N/A	N/A
RGNX	REGENXBIO INC	$640.55M	-53.30%	-30.80%	-36.03%	-29.10%	0.79	2.94	79.10%	-100.60%	-88.33%
TNGX	TANGO THERAPEUTICS INC	$902.32M	-79.70%	-49.30%	-73.48%	-60.90%	0.76	4.75	100.00%	-599.10%	-598.40%
ALEC	ALECTOR INC	$148.78M	-112.10%	-26.40%	-42.36%	-35.90%	4.01	3.78	100.00%	-142.10%	-142.04%
RZLT	REZOLUTE INC	$846.36M	-65.00%	-58.90%	-45.49%	-86.50%	0.08	14.37	N/A	N/A	N/A
GNPX	GENPREX INC	$3.86M	-822.20%	-393.20%	-1,242.53%	-10,819.70%	1.75	0.84	N/A	N/A	N/A
ORIC	ORIC PHARMACEUTICALS INC	$1.28B	-51.80%	-47.10%	-41.74%	-64.20%	0.07	16.13	N/A	N/A	N/A
DTIL	PRECISION BIOSCIENCES INC	$90.48M	-35.90%	-15.20%	-18.23%	-54.20%	1.52	6.63	100.00%	-43.00%	-39.94%
PRTA	PROTHENA CORP PUBLIC LTD CO	$578.67M	-67.90%	-59.50%	-78.99%	-1,191.10%	0.23	5.69	100.00%	-2,929.30%	-2,530.46%
SANA	SANA BIOTECHNOLOGY INC	$1.18B	-115.30%	-54.00%	-76.84%	-120.30%	1.95	2.47	N/A	N/A	N/A
GLSI	GREENWICH LIFESCIENCES INC	$125.53M	-700.90%	-455.70%	-1,249.93%	1,302.30%	1.17	1.85	N/A	N/A	N/A
EYPT	EYEPOINT PHARMACEUTICALS INC	$900.75M	-54.30%	-41.80%	-45.71%	-62.60%	0.22	7.85	93.30%	-261.90%	-261.73%
AVIR	ATEA PHARMACEUTICALS INC	$278.13M	-31.30%	-29.30%	-33.14%	-42.80%	0.07	19.94	N/A	N/A	N/A
GPCR	STRUCTURE THERAPEUTICS INC	$1.92B	-21.30%	-20.30%	-22.96%	-25.90%	0.06	20.48	N/A	N/A	N/A
SILO	SILO PHARMA INC	$5.10M	-94.40%	-68.60%	-87.28%	-305.10%	0.35	6.07	91.90%	-6,789.20%	-6,782.19%
APGE	APOGEE THERAPEUTICS INC	$3.37B	-34.60%	-32.80%	-37.93%	-40.70%	0.06	16.36	N/A	N/A	N/A
AVXL	ANAVEX LIFE SCIENCES CORP	$684.57M	-45.70%	-40.20%	-53.09%	402.40%	0.13	8.93	N/A	N/A	N/A
HOWL	WEREWOLF THERAPEUTICS INC	$59.90M	-111.90%	-62.70%	-87.95%	-174.60%	1.23	5.30	N/A	N/A	N/A
AVTX	AVALO THERAPEUTICS INC	$237.14M	-48.50%	-35.90%	-41.14%	-3,275.50%	0.21	12.44	242.20%	-10,479.80%	-10,946.03%
TRDA	ENTRADA THERAPEUTICS INC	$264.36M	-17.80%	-14.60%	-17.93%	-17.40%	0.18	18.64	100.00%	-92.30%	-96.77%
SPRY	ARS PHARMACEUTICALS INC	$885.48M	-21.80%	-15.90%	-17.82%	-17.50%	0.63	6.17	93.70%	-42.70%	-42.49%
CMPX	COMPASS THERAPEUTICS INC	$517.18M	-53.10%	-46.10%	-60.32%	-65.30%	0.25	7.66	N/A	N/A	N/A
KYTX	KYVERNA THERAPEUTICS INC	$301.42M	-64.90%	-56.10%	-84.94%	-89.40%	0.23	5.39	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$2.03B	-70.00%	-48.00%	-50.05%	-212.70%	0.48	10.10	89.40%	-382.50%	-360.75%
NGNE	NEUROGENE INC	$488.96M	-33.30%	-30.30%	-29.94%	-44.10%	0.09	18.07	N/A	N/A	N/A
LRMR	LARIMAR THERAPEUTICS INC	$332.95M	-62.90%	-54.00%	-80.90%	-71.70%	0.25	5.46	N/A	N/A	N/A
VYGR	VOYAGER THERAPEUTICS INC	$259.04M	-37.60%	-28.90%	-38.29%	-37.90%	0.32	5.43	100.00%	-349.20%	-347.02%
ACET	ADICET BIO INC	$62.03M	-59.10%	-50.70%	-67.11%	-93.10%	0.19	9.34	N/A	N/A	N/A
XFOR	X4 PHARMACEUTICALS INC	$23.39M	29.30%	8.80%	23.07%	23.40%	4.67	3.70	82.40%	46.50%	76.58%
NVCT	NUVECTIS PHARMA INC	$170.82M	-150.80%	-94.80%	-130.79%	260.90%	0.60	2.67	N/A	N/A	N/A
YDES	YD BIOPHARMA LTD	$801.19M	N/A	-12.30%	-20.99%	401.50%	0.04	13.18	30.40%	-276.60%	-271.52%
VRDN	VIRIDIAN THERAPEUTICS INC	$1.93B	-55.10%	-49.90%	-64.39%	-64.00%	0.13	11.01	100.00%	-112,806.90%	-111,835.74%
ANVS	ANNOVIS BIO INC	$40.92M	-206.00%	-158.30%	-162.26%	18,400.10%	0.17	7.65	N/A	N/A	N/A
PRAX	PRAXIS PRECISION MEDICINES INC	$4.18B	-60.10%	-54.80%	-62.10%	-103.50%	0.12	6.31	100.00%	-3,232.60%	-3,232.61%
ROIV	ROIVANT SCIENCES LTD	$13.65B	-10.10%	-8.70%	-9.14%	-12.90%	0.05	40.54	96.30%	-2,111.80%	-1,935.92%
SNGX	SOLIGENIX INC	$6.64M	-274.80%	-129.20%	-518.78%	439.40%	2.15	1.47	N/A	N/A	N/A
AARD	AARDVARK THERAPEUTICS INC	$231.94M	N/A	N/A	N/A	N/A	0.08	14.04	N/A	N/A	N/A
ATOS	ATOSSA THERAPEUTICS INC	$114.96M	-42.80%	-39.50%	-49.78%	10,558.10%	0.12	9.17	N/A	N/A	N/A
CDT	CONDUIT PHARMACEUTICALS INC	$1.09M	N/A	-349.40%	-507.47%	33,919.60%	1.26	1.45	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Nov 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Mimedx Group (NASDAQ:MDXG)

Mimedx Group (NASDAQ:MDXG) is the #1 top biotech stock out of 624 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Mimedx Group (NASDAQ:MDXG) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: B.

Mimedx Group (NASDAQ:MDXG) has a Due Diligence Score of 45, which is 22 points higher than the biotech industry average of 23.

MDXG passed 14 out of 33 due diligence checks and has strong fundamentals. Mimedx Group has seen its stock return 11.68% over the past year, overperforming other biotech stocks by 32 percentage points.

Mimedx Group has an average 1 year price target of $12.00, an upside of 56.86% from Mimedx Group's current stock price of $7.65.

Mimedx Group stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Mimedx Group, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the #2 top biotech stock out of 624 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Incyte (NASDAQ:INCY) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: B.

Incyte (NASDAQ:INCY) has a Due Diligence Score of 60, which is 37 points higher than the biotech industry average of 23.

INCY passed 19 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock return 26.12% over the past year, overperforming other biotech stocks by 46 percentage points.

Incyte has an average 1 year price target of $88.75, a downside of -5.06% from Incyte's current stock price of $93.48.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Incyte, 50% have issued a Strong Buy rating, 0% have issued a Buy, 41.67% have issued a hold, while 8.33% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #3 top biotech stock out of 624 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 36, which is 13 points higher than the biotech industry average of 23.

TBPH passed 11 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 77.91% over the past year, overperforming other biotech stocks by 98 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 75.08% from Theravance Biopharma's current stock price of $14.66.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.57%, which is 8 percentage points higher than the biotech industry average of 2.67%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.32%, which is the same as the biotech industry average of 2.67%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 37.2% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)

Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.51%, which is -2 percentage points lower than the biotech industry average of 2.67%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 68.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.64% in the last day, and up 2.9% over the last week. Cabaletta Bio was the among the top gainers in the biotechnology industry, gaining 46.15% yesterday.

Cabaletta Bio shares are trading higher after Cantor Fitzgerald maintained its overweight on the stock and raised Its price target from $15 to $30.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -11.08% in the past year. It has overperformed other stocks in the biotech industry by 9 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 78.95% in the past year. It has overperformed other stocks in the biotech industry by 99 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 57, which is 43 points higher than the biotech industry average of 14. It passed 4 out of 7 valuation due diligence checks.

Incyte's stock has gained 26.12% in the past year. It has overperformed other stocks in the biotech industry by 46 percentage points.

Are biotech stocks a good buy now?

58.9% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 59.32% over the next year.

2.89% of biotech stocks have a Zen Rating of A (Strong Buy), 4.96% of biotech stocks are rated B (Buy), 44.21% are rated C (Hold), 33.47% are rated D (Sell), and 14.46% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -9.17x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Mimedx Group (NASDAQ:MDXG)

2. Incyte (NASDAQ:INCY)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Mimedx Group (NASDAQ:MDXG)

2. Incyte (NASDAQ:INCY)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.